Therapy of Mucormycosis

Therapy of Mucormycosis

Despite the recent introduction of mold-active agents (posaconazole and isavuconazole), in addition to amphotericin B products, to our armamentarium against mucormycosis, many uncertainties remain for the management of this uncommon opportunistic infection, as there are no data from prospective rand...

Full description

Bibliographic Details
Main Authors:	Nikolaos V. Sipsas, Maria N. Gamaletsou, Amalia Anastasopoulou, Dimitrios P. Kontoyiannis
Format:	Article
Language:	English
Published:	MDPI AG 2018-07-01
Series:	Journal of Fungi
Subjects:	mucormycosis treatment amphotericin B posaconazole isavuconazole surgery leukemia stem cell transplantation
Online Access:	http://www.mdpi.com/2309-608X/4/3/90

Similar Items

Efficacy of combination therapy of amphotericin and posaconazole in treatment of mucormycosis
by: Sridhara S, et al.
Published: (2023-03-01)

Silent choker: Unveiling tracheal stenosis as an atypical manifestation of mucormycosis
by: Mehul G Kaliya, et al.
Published: (2024-01-01)

Mucormycosis: modern diagnostics and treatment, existing problems and new trends in antifungal therapy
by: Popova M.O., et al.
Published: (2021-09-01)

Posaconazole as single or adjunctive antifungal in mucormycosis of the maxilla: systematic review and meta-analysis
by: Pardiwala Arwa, et al.
Published: (2023-01-01)

A rare case of pulmonary mucormycosis complicated by hydropneumothorax, successfully treated with non‐surgical therapies
by: Qiliang Liu, et al.
Published: (2022-06-01)

Successful treatment of pulmonary mucormycosis in a child with aplastic anemia
by: Ye. A. Nikitina, et al.
Published: (2014-07-01)

Successful treatment of pulmonary mucormycosis in a child with aplastic anemia
by: Ye. A. Nikitina, et al.
Published: (2014-07-01)

Isavuconazole as salvage therapy for mucormycosis
by: Bianca Graves, et al.
Published: (2016-03-01)

Successful treatment of rhino-cerebral mucormycosis with dual antifungal therapy and minimal surgical debridement
by: Lauren Bougioukas, et al.
Published: (2022-01-01)

An unusual ulcer: A case of cutaneous mucormycosis caused by Rhizopus oryzae
by: Bradley J. Gardiner, et al.
Published: (2015-03-01)

The successful use of amphotericin B followed by oral posaconazole in a rare case of invasive fungal sinusitis caused by co-infection with mucormycosis and aspergillus
by: Sharana Mahomed, et al.
Published: (2015-01-01)

Mucormycosis in a Severe Trauma Patient Treated with a Combination of Systemic Posaconazole and Topical Amphotericin B—Case Report
by: Filip Keller, et al.
Published: (2023-09-01)

Mucormycosis and aspergillosis: The deadly duo in COVID-19—a case report
by: Bijaya Mohanty, et al.
Published: (2022-01-01)

Intestinal mucormycosis in an adult with H1N1 pneumonia on extracorporeal membrane oxygenation
by: G J Himaal Dev, et al.
Published: (2021-01-01)

Post-COVID mucormycosis: A retrospective observational study
by: Nurani Shaik, et al.
Published: (2022-01-01)

Pharmacoeconomic evaluation of isavuconazole, posaconazole, and voriconazole for the treatment of invasive mold diseases in hematological patients: initial therapy prior to pathogen differential diagnosis in China
by: Guangxin Han, et al.
Published: (2023-12-01)

A study of mucormycosis in second wave of COVID-19
by: H.T. Lathadevi, et al.
Published: (2024-04-01)

Disseminated Saksenaea infection in an immunocompromised host associated with a good clinical outcome: a case report and review of the literature
by: N. Davidson, et al.
Published: (2020-10-01)

Disseminated pulmonary mucormycosis with concomitant tuberculosis infection in a diabetic patient
by: Priyamvadha Ramesh, et al.
Published: (2020-01-01)

Mucormycosis In A Patient With Acute Lymphoblastic Leukemia: A Case Report
by: Sinan Demircioğlu, et al.
Published: (2019-01-01)

Posaconazole or isavuconazole as sole or predominant antifungal therapy for COVID-19-associated mucormycosis. A retrospective observational case series
by: Rajeev Soman, et al.
Published: (2022-07-01)

Invasive rhino-orbito-cerebral mucormycosis in a diabetic patient – the need for prompt treatment
by: Vanessa Chow, et al.
Published: (2015-06-01)

MUCORMYCOSIS IN ONCOHEMATOLOGY PATIENTS (results of the prospective study)
by: N. N. Klimko, et al.
Published: (2017-06-01)

Disseminated mucormycosis in a child with acute lymphoblastic leukemia: a case report and autopsy findings
by: Javier A. Teco-Cortés, et al.
Published: (2023-01-01)

Mucormycosis: A diagnostic and therapeutic challenge: A Case Report
by: D. Wickramasinghe, et al.
Published: (2021-10-01)

Mucormycosis: Effect of Comorbidities and Repeated Debridement on the Outcome
by: Harshavardhan N Reddy, et al.
Published: (2019-04-01)

Mucormycosis: Effect of Comorbidities and Repeated Debridement on the Outcome
by: Harshavardhan N Reddy, et al.
Published: (2019-04-01)

Comparative evaluation of isavuconazonium sulfate, voriconazole, and posaconazole for the management of invasive fungal infections in an academic medical center
by: Edward T. Van Matre, et al.
Published: (2019-03-01)

Outcomes of early anti-fungal therapy with aggressive surgical resection in pulmonary mucormycosis
by: Mohan Venkatesh Pulle, et al.
Published: (2021-01-01)

Epidemiology and management of mucormycosis in India – Pre- and Post-COVID-19
by: Nandini Sethuraman
Published: (2021-01-01)

Clinical and microbiological features and outcomes of mucormycosis in critically ill patients
by: Kathrin Rothe, et al.
Published: (2021-08-01)

Clinical and Paraclinical Survey of Hospitalised Cases of Mucormycosis in Two Centres in Ghaemshahr and Sari during 2011-2018
by: Lotfollah Davoodi, et al.
Published: (2023-11-01)

The Role of Retrobulbar Injection of Amphotericin B in the Management of Orbital Mucormycosis in a Tertiary Care Centre—Prospective Analytical Study
by: A Yogeswari, et al.
Published: (2023-01-01)

Rhinocerebral maxillary mucormycosis: A palatal ulcer
by: D N S V Ramesh, et al.
Published: (2020-01-01)

Isolated renal mucormycosis in children: A case report and review of the literature
by: Sachit Anand, et al.
Published: (2021-01-01)

A case of invasive pulmonary mucormycosis resulting from short courses of corticosteroids in a well-controlled diabetic patient
by: Kathy Hoang, et al.
Published: (2020-09-01)

Isavuconazole in the treatment of invasive aspergillosis and mucormycosis infections
by: Donnelley MA, et al.
Published: (2016-06-01)

Mucormycosis of the head and neck
by: Santosh Kumar Swain, et al.
Published: (2018-01-01)

Abdominal mucormycosis in a child: a case report
by: Felipe Rezende Caino de Oliveira, et al.

Post COVID-19 mucormycosis: A case series
by: Mala Vinod Kaneria, et al.
Published: (2021-01-01)